Advertisement

Topics

CytoReason Company Profile

01:15 EDT 25th April 2018 | BioPortfolio


News Articles [2 Associated News Articles listed on BioPortfolio]

Using AI to personalise drug treatments

CytoReason, an immune-focused artificial intelligence technology company generates insights to reveal complex patterns in a variety of biological data

CytoReason Cements Proof-of-Concept with Machine-Learning-Facilitated Biomarker Breakthrough in Anti-TNFα Treatment Failure in Inflammatory Bowel Disease. New Data Published in Gut

CytoReason’s proprietary technology demonstrates ability to reconstruct hidden cellular signals, extrapolate one tissue to another and identify immune system relationships capab...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

More Information about "CytoReason" on BioPortfolio

We have published hundreds of CytoReason news stories on BioPortfolio along with dozens of CytoReason Clinical Trials and PubMed Articles about CytoReason for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CytoReason Companies in our database. You can also find out about relevant CytoReason Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record